#cd7814

Study of Hospital-Associated Infection – Clostridioides difficile Identified NpmA In the Genome of a Clinical Isolate

Clostridioides difficile: a potential source of NpmA in the clinical environment

Jane W Marsh,1,2 Marissa P Pacey,1,2,3 Chinelo Ezeonwuka,1,2 Sara L Ohm,1,2 Dan Snyder,4 Vaughn S Cooper,4 Lee H Harrison,1,2 Yohei Doi,1,3,5 and Mustapha M Mustapha1,2,3

Aminoglycosides are widely used to treat MDR Gram-negative bacterial infections with bactericidal activity mediated by binding the 16S…